Psilocybin, a woman in her eighties, and a rare morning of full sentences
A Japanese-American woman in her eighties had spent five years losing language to Alzheimer's, one syllable at a time. She could not walk on her own, and often did not know her family.
Under medical supervision in Brazil, she was given a large dose of psilocybin. Three days later she was recounting memories and speaking in full sentences [201]. A week in, she was recognising family, asking where they were, pointing out cars that looked out of place. The team is careful about the story. It is one patient, no scans, no biomarkers, no cognitive tests, purely observational. They think psilocybin may have briefly opened a channel through the plaques and let dormant networks fire again [201]. In a separate Danish study of chronic cluster headache patients, psilocybin improved sleep quality in proportion to how many attacks it prevented [108].
What each field noticed (2)
Woman With Alzheimer's Shows Striking Improvement After Taking Magic Mushrooms
The Hub frames this as the kind of single case that pushes a whole research programme forward. Alzheimer's affects roughly 40 million people worldwide, and treatments so far barely nudge the trajectory [201]. A trial testing whether psilocybin protects the aging brain is already running. The piece leans on cognitive reserve, the idea that some networks are still there, waiting, if you can wake them.
Read the storyPsilocybin improves sleep quality in patients with chronic cluster headaches
Copenhagen researchers found that patients who took psilocybin slept better, and the size of the sleep gain tracked the drop in headache attacks. Cluster headaches strike mostly at night, so patients often live in a state of chronic sleep debt that reshapes the brain's white matter and grey matter density over years [108]. Better sleep may be the mechanism, not a side effect.
Read the story






